CACNA1H and diabetic neuropathy: Disrupting the interaction between Cav3.2 and USP5 using the TAT-cUBP1-USP5 peptide has been shown to reduce the levels of the Cav3.2 calcium channel in vitro, which attenuates thermal hyperalgesia in diabetic neuropathy animals (137, 138).